Rifaximin - Revision history

Danbot: Add AntibioticDose SMW query table for dynamic indications by disease

2026-03-20T20:38:31Z

Add AntibioticDose SMW query table for dynamic indications by disease

@@ Line 12: / Line 12: @@
 *IBS, diarrhea-predominant: 550mg PO tid x14 days
 **May repeat dose up to 2x if recurrent disease
 ==Pediatric Dosing==
 ===For > 12 yrs old===
 *Traveler's diarrhea, E. coli-induced: 200mg PO tid x3 days

2019-09-23T22:18:58Z

← Older revision		Revision as of 22:18, 23 September 2019
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: Antibiotic		*Type: [[Antibiotic]]
	*Dosage Forms: 200, 550		*Dosage Forms: 200, 550
	*Routes of Administration: Oral		*Routes of Administration: Oral
Line 52:		Line 52:
	<Epocrates, UpToDate>		<Epocrates, UpToDate>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]] [[Category:GI]]

2016-07-20T18:24:56Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 18:24, 20 July 2016
Line 6:		Line 6:

	==Adult Dosing==		==Adult Dosing==
	*Traveler's diarrhea, E. coli-induced: ~~200 mg~~ PO tid x3 days		*Traveler's diarrhea, E. coli-induced: 200mg PO tid x3 days

	*Hepatic encephalopathy: ~~550 mg~~ PO bid		*Hepatic encephalopathy: 550mg PO bid

	*IBS, diarrhea-predominant: ~~550 mg~~ PO tid x14 days		*IBS, diarrhea-predominant: 550mg PO tid x14 days
	**May repeat dose up to 2x if recurrent disease		**May repeat dose up to 2x if recurrent disease

	==Pediatric Dosing==		==Pediatric Dosing==
	===For > 12 yrs old===		===For > 12 yrs old===
	*Traveler's diarrhea, E. coli-induced: ~~200 mg~~ PO tid x3 days		*Traveler's diarrhea, E. coli-induced: 200mg PO tid x3 days

	==Special Populations==		==Special Populations==

2016-07-14T03:35:16Z

Special Populations

← Older revision		Revision as of 03:35, 14 July 2016
Line 18:		Line 18:

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]:		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C
	*[[Lactation risk categories\|Lactation risk]]:		*[[Lactation risk categories\|Lactation risk]]: Infant risk cannot be ruled out
	===Renal Dosing===		===Renal Dosing===
	*No adjustment		*No adjustment

2016-07-14T01:22:17Z

Adult Dosing

← Older revision		Revision as of 01:22, 14 July 2016
Line 11:		Line 11:

	*IBS, diarrhea-predominant: 550 mg PO tid x14 days		*IBS, diarrhea-predominant: 550 mg PO tid x14 days
	**May repeat dose up to 2x if recurrent dz		**May repeat dose up to 2x if recurrent disease

	==Pediatric Dosing==		==Pediatric Dosing==

2016-07-14T01:18:17Z

Contraindications

← Older revision		Revision as of 01:18, 14 July 2016
Line 29:		Line 29:
	*Allergy to class/drug		*Allergy to class/drug
	*caution if hepatic impairment (Child-Pugh Class C)		*caution if hepatic impairment (Child-Pugh Class C)
	*caution if recent ~~abx~~-associated colitis		*caution if recent antibiotic-associated colitis

	==Adverse Reactions==		==Adverse Reactions==

2016-07-09T09:09:54Z

Text replacement - " ==" to "=="

← Older revision		Revision as of 09:09, 9 July 2016
Line 14:		Line 14:

	==Pediatric Dosing==		==Pediatric Dosing==
	===For > 12 yrs old ===		===For > 12 yrs old===
	*Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days		*Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days

2016-07-03T09:59:06Z

Text replacement - "rxn" to "reaction"

2016-03-22T15:53:21Z

Text replacement - "Category:Drugs" to "Category:Pharmacology"

2016-01-20T14:26:09Z

annotation

← Older revision		Revision as of 14:26, 20 January 2016
Line 21:		Line 21:
	*[[Lactation risk categories\|Lactation risk]]:		*[[Lactation risk categories\|Lactation risk]]:
	===Renal Dosing===		===Renal Dosing===
	*No ~~adjustmen~~		*No adjustment

	===Hepatic Dosing===		===Hepatic Dosing===
	*No adjustment		*No adjustment